Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

6,500

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
PreDiabetesAbdominal ObesityHypertensionDyslipidemias
Interventions
DRUG

Berberine plus lifestyle intervention

"berberine hydrochloride 500mg twice a day plus lifestyle intervention. Lifestyle intervention is based onChinese guideline on the primary prevention of cardiovascular diseases and Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition), including health education on smoking, alcohol consumption, diet, physical activity and weight loss, etc."

BEHAVIORAL

Placebo plus lifestyle intervention

"Placebo with identical shape, colour, odour and taste twice a day plus lifestyle intervention. Lifestyle intervention is based onChinese guideline on the primary prevention of cardiovascular diseases and Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition), including health education on smoking, alcohol consumption, diet, physical activity and weight loss, etc."

Trial Locations (1)

Unknown

Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT05749874 - Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus | Biotech Hunter | Biotech Hunter